EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors

Xueman Deng iD, Duoguang Wu, Luting Ni, Wei Li, Zhijun Liu, Jiewei Liu iD, Jieqiong Liu iD

Cancer Medicine · 2026-11 · 15 (11)

DOI: 10.1002/cam4.72280 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Medicine, online erschienen am 07.11.2026. Verfasst von Xueman Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Lung Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Major Science and Technology Projects of China, Natural Science Foundation of China, Chinese Society of Clinical Oncology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Local therapy has recently been applied to treat oligometastatic cancer across various malignant cancers. However, definitive evidence for local treatment regimens remains lacking. We aimed to evaluate the clinical outcomes of combining local therapy with systemic treatment for patients with oligometastatic solid tumors including breast cancer, liver cancer, and non‐small cell lung cancer (NSCLC) in a multicenter retrospective study.

Methods

From January 2013 to December 2023, 575 patients with fewer than or equal to five metastases of breast cancer, liver cancer, and NSCLC in three tertiary university hospitals were analyzed retrospectively. The primary endpoint was overall survival (OS). The secondary endpoints included progression‐free survival (PFS) and prognostic factors affecting the treatment outcomes.

Results

Before propensity score matching, significant differences were observed in both OS and PFS between the local therapy plus systemic therapy and systemic therapy alone groups ( p < 0.001 and p < 0.001). After PSM, PFS remained significantly different ( p = 0.017), but OS did not ( p = 0.076). In liver cancer, before PSM analysis showed a significant PFS benefit ( p = 0.011), which was absent after PSM for both OS and PFS ( p = 0.568 and p = 0.363). For both breast cancer and NSCLC patients, no significant differences in OS or PFS were found after PSM.

Conclusions

Local treatment of solitary metastatic lesions showed that no statistically significant difference was observed in OS or PFS of patients with advanced oligometastatic breast, liver cancer, and NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsLung NeoplasmsBreast NeoplasmsCarcinoma, Non-Small-Cell LungHumansFemaleRetrospective StudiesPrognosisMiddle AgedMaleAgedNeoplasm MetastasisProgression-Free SurvivalTreatment OutcomeAdult

Stichwörter der Autor:innen

local treatmentoligometastaticsolid tumorssystemic treatment

Autor:innen und Institutionen

  • Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Thoracic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Anesthesiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Center of Precision Medicine, Shenshan Central Hospital, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Shanwei, China.

ORCID-Profile: Xueman Deng, Jiewei Liu, Jieqiong Liu

Förderung

  • National Major Science and Technology Projects of China
  • Natural Science Foundation of China
  • Chinese Society of Clinical Oncology
  • Guangdong Provincial Clinical Research Center for Breast Diseases
  • Sun Yat-Sen Memorial Hospital Clinical Research 5010 Program
  • Sun Yat-Sen Memorial Hospital Medical Scientist Program
  • Guangdong Provincial Key Laboratory of Cancer Pathogenesis and Precision Diagnosis and Treatment
  • Beijing Zhongguancun Precision Medicine Foundation

Zitieren

APA

Deng, X., Wu, D., Ni, L., Li, W., Liu, Z., Liu, J., & Liu, J. (2026). Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72280

Vancouver

Deng X, Wu D, Ni L, Li W, Liu Z, Liu J, et al. Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72280

BibTeX
@article{Deng2026,
  author = {Deng, Xueman and Wu, Duoguang and Ni, Luting and Li, Wei and Liu, Zhijun and Liu, Jiewei and Liu, Jieqiong},
  title = {Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/cam4.72280}
}
Kostenlos starten →